Your session is about to expire
← Back to Search
Transcranial Rotating Permanent Magnet Stimulator (TRPMS) for Neurogenic Bladder
N/A
Waitlist Available
Led By Rose Khavari, MD
Research Sponsored by Rose Khavari, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, after treatment and 4 month follow up
Awards & highlights
Study Summary
This study is evaluating whether brain centers are involved in initiating voiding in patients with neurogenic bladder dysfunction.
Eligible Conditions
- Neurogenic Bladder
- Multiple Sclerosis
- Urinary Retention
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, after treatment and 4 month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, after treatment and 4 month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in Brain Activity After Treatment Measured Using Functional MRI
Secondary outcome measures
Changes in %Post-Void Residual/Bladder Capacity (PVR/BC) Following Treatment
Changes in Liverpool Nomogram Following Treatment
Changes in Non-instrumented Uroflow Variable Qmax Following Treatment
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Subjects with Multiple Sclerosis and Voiding DysfunctionExperimental Treatment1 Intervention
Subjects with Multiple Sclerosis (MS) and voiding dysfunction (VD). In this group 'Transcranial Rotating Permanent Magnet Stimulator (TRPMS)' device will be used.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Rotating Permanent Magnet Stimulator (TRPMS)
2018
N/A
~20
Find a Location
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,357 Previous Clinical Trials
4,315,175 Total Patients Enrolled
Rose Khavari, M.D.Lead Sponsor
4 Previous Clinical Trials
259 Total Patients Enrolled
The Methodist Hospital Research InstituteLead Sponsor
271 Previous Clinical Trials
80,364 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger